Department of Epidemiology (PM), University of Alabama at Birmingham, Birmingham, Alabama; Department of Medicine (CBB), Emory University, Atlanta Veterans Affairs Medical Center (CBB) Atlanta, Georgia; and Department of Medicine (DS), Columbia University Medical Center, New York, New York.
Am J Med Sci. 2014 Aug;348(2):129-34. doi: 10.1097/MAJ.0000000000000314.
The 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) was recently published. This guideline recommended that older adults (≥60 years) without diabetes or chronic kidney disease with systolic blood pressure (SBP) ≥150 mm Hg or diastolic blood pressure (DBP) ≥90 mm Hg be initiated on antihypertensive medication with a treatment goal SBP/DBP <150/90 mm Hg. In contrast, the previous 3 JNC guidelines recommended treatment for these individuals be initiated at SBP/DBP ≥140/90 mm Hg with goal SBP/DBP <140/90 mm Hg. In this article, we review randomized trials of antihypertensive medication and observational data on SBP and DBP with cardiovascular outcomes among older adults, possible explanations underlying the different findings from these randomized trials and observational studies, and contemporary antihypertensive treatment patterns among older U.S. adults. In closing, we highlight future research needs related to hypertension and outcomes among older adults.
最近发表了《2014 年成人高血压管理循证指南》报告,该报告的成员由第八届联合国家委员会(JNC 8)任命。该指南建议,无糖尿病或慢性肾脏病的老年人(≥60 岁),收缩压(SBP)≥150mmHg 或舒张压(DBP)≥90mmHg 者,应开始使用降压药物治疗,治疗目标 SBP/DBP<150/90mmHg。相比之下,之前的 3 项 JNC 指南建议在 SBP/DBP≥140/90mmHg 时开始治疗,目标 SBP/DBP<140/90mmHg。在本文中,我们回顾了降压药物的随机试验以及老年人 SBP 和 DBP 与心血管结局的观察性数据,讨论了这些随机试验和观察性研究结果不同的可能解释,以及当代美国老年人的降压治疗模式。最后,我们强调了与老年人高血压和结局相关的未来研究需求。